Broadcom
AVGO
Alibaba
BABA
NVIDIA
NVDA
Taiwan Semiconductor
TSM
Meta Platforms
META
US Stock MarketDetailed Quotes
RGNX Regenxbio
- 6.670
- -0.050-0.74%
Close Feb 26 16:00 ET
330.47MMarket Cap-1.33P/E (TTM)
6.860High6.560Low671.62KVolume6.830Open6.720Pre Close4.51MTurnover1.65%Turnover RatioLossP/E (Static)49.55MShares28.80052wk High1.10P/B270.98MFloat Cap6.44052wk Low--Dividend TTM40.63MShs Float85.100Historical High--Div YieldTTM4.46%Amplitude6.440Historical Low6.711Avg Price1Lot Size
About Regenxbio Company
REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.
Company Profile
SymbolRGNX
Company NameRegenxbio
Listing DateSep 17, 2015
Issue Price22.00
Founded2008
CEOMr. Curran Simpson
MarketNASDAQ
Employees344
Fiscal Year Ends12-31
Address9804 Medical Center Drive
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-240-552-8181
Websitehttp://www.regenxbio.com
Company Executives
- Name
- Position
- Salary
- Curran Simpson
- Director, President and Chief Executive Officer
- 2.95M
- Patrick J. Christmas
- Executive Vice President and Chief Legal Officer
- --
- Dr. Olivier Danos, PhD
- Executive Vice President and Chief Scientific Officer
- 2.99M
- Stephen Pakola, M.D.
- Executive Vice President and Chief Medical Officer
- 3.31M
- Mitchell Chan
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Allan M. Fox
- Chairman of the Board
- 354.98K
- Daniel Tasse
- Lead Independent Director
- 334.98K
- Dr. Argeris N. Karabelas, PhD
- Independent Director
- 352.48K
- Jennifer Zachary
- Independent Director
- 329.98K
- Dr. David C. Stump,M.D.
- Independent Director
- 339.98K
- Dr. Alexandra Glucksmann, PhD
- Independent Director
- 327.48K
- George V. Migausky
- Independent Director
- 339.98K
- Dr. Jean Bennett, M.D.,Pd.D
- Independent Director
- 324.98K
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.